STAGE III LUNG CANCER AJCC V8

This early-stage trial tested whether adding immunotherapy drugs (durvalumab, monalizumab, or oleclumab) to radiation therapy is safe for people with locally advanced non-small cell lung cancer that cannot be removed by surgery. Twenty-six participants received different combinat…

This study looked at people with stage 2 or 3 non-small cell lung cancer that cannot be removed by surgery. Participants received standard chemotherapy along with different doses of proton beam radiation to find the most effective dose. The goal was to improve how long the cancer…

This early-phase study tested a treatment for people with advanced lung cancer that blocks their airways. Doctors injected a light-sensitive drug into the blood, then used a special laser to activate it inside the tumor, aiming to shrink it and relieve symptoms. The study include…

This study tested a health coaching program called BeWell360-CG for caregivers of people with advanced lung cancer. The goal was to see if coaching could reduce caregiver stress and improve their quality of life. 55 caregivers took part in the program, which included coaching ses…

This study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer that hadn't spread. Participants got a small heart monitor implanted to track heart problems that might otherwise go unnoticed. The goal was to better understand a…

This study collected tumor tissue and blood samples from 64 people with advanced or treatment-resistant cancers. The goal was to store these samples for future research on how genes affect cancer and response to treatment. No direct treatment was given; the focus was on building …